Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-22-012380

← back to feed
Filed
May 6, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 6, 2022 957.54M sh
Current Liabilities Q1 2022 · Mar 31, 2022 $8.59M
Current Liabilities Q1 2022 · Dec 31, 2021 $8.16M
Total Liabilities Q1 2022 · Mar 31, 2022 $8.7M
Total Liabilities Q1 2022 · Dec 31, 2021 $8.32M
Current Assets Q1 2022 · Mar 31, 2022 $3.93M
Current Assets Q1 2022 · Dec 31, 2021 $2.37M
Total Assets Q1 2022 · Mar 31, 2022 $4.59M
Total Assets Q1 2022 · Dec 31, 2021 $3.02M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$418.65K
Stockholders Equity Q1 2022 · Mar 31, 2021 −$6.88M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$6.57M
Eps Basic Q1 2022 · Mar 31, 2021 $0.00
Sga Expense Q1 2022 · Mar 31, 2021 $306.59K
Rd Expense Q1 2022 · Mar 31, 2021 $87.77K
Net Income Q1 2022 · Mar 31, 2021 −$940.66K
Operating Income Q1 2022 · Mar 31, 2021 −$665.01K